Finance

Lists
3349:TYO
Cosmos Pharmaceutical Corp
6 327,00 JP¥
+0,21%
(+13,00) 1D
7 қаз., 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 3349...
Open
6 343 JP¥
High
6 407 JP¥
Low
6 307 JP¥
Mkt. cap
506,17 млрд
Avg. vol.
436,37 м.
Volume
258,10 м.
Dividend
1,30%
Quarterly dividend
21 JP¥
Ex-dividend date
2026 ж. 27 қар.
P/E ratio
15,65
52-wk high
8 590 JP¥
52-wk low
5 615 JP¥
EPS
404 JP¥
Shares outstanding
19,80 млн
No. of employees
6 мың
Open
6 343 JP¥
High
6 407 JP¥
Low
6 307 JP¥
Mkt. cap
506,17 млрд
Avg. vol.
436,37 м.
Volume
258,10 м.
Dividend
1,30%
Quarterly dividend
21 JP¥
Ex-dividend date
2026 ж. 27 қар.
P/E ratio
15,65
52-wk high
8 590 JP¥
52-wk low
5 615 JP¥
EPS
404 JP¥
Shares outstanding
19,80 млн
No. of employees
6 мың
News stories
From web sources and news partners
About Cosmos Pharmaceutical Corp
CEO-
Employees5,98 мың
Foundedжел. 1983
Headquarters-
SectorDrug
Websitecosmospc.co.jp
Next call 6 күннен кейін
13 қаз., сс, 00:00
Fiscal period
Q1 2027
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
- / 291,21 млрд
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025 ж. там.
2025 ж. қар.
2026 ж. ақп.
2026 ж. мам.
Revenue
272,39 млрд
264,78 млрд
273,20 млрд
289,20 млрд
Cost of goods sold
215,22 млрд
209,07 млрд
216,15 млрд
229,46 млрд
Cost of revenue
215,22 млрд
209,07 млрд
216,15 млрд
229,46 млрд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
45,64 млрд
46,57 млрд
45,83 млрд
26,43 млрд
Operating expense
45,64 млрд
46,57 млрд
45,83 млрд
49,08 млрд
Total operating expenses
260,86 млрд
255,64 млрд
261,97 млрд
278,54 млрд
Operating income
11,54 млрд
9,14 млрд
11,23 млрд
10,66 млрд
Other non operating income
627,00 млн
801,00 млн
667,00 млн
695,00 млн
EBT including unusual items
12,09 млрд
9,58 млрд
11,96 млрд
10,60 млрд
EBT excluding unusual items
12,08 млрд
9,85 млрд
11,81 млрд
11,12 млрд
Income tax expense
3,92 млрд
3,10 млрд
3,86 млрд
1,30 млрд
Effective tax rate
32,40%
32,35%
32,26%
12,26%
Other operating expenses
-
-
-
-
Net income
8,17 млрд
6,48 млрд
8,10 млрд
9,30 млрд
Net profit margin
3,00%
2,45%
2,96%
3,21%
Earnings per share
-
-
-
-
Interest and investment income
27,00 млн
19,00 млн
16,00 млн
12,00 млн
Interest expense
-110,00 млн
-107,00 млн
-107,00 млн
-257,00 млн
Net interest expenses
-83,00 млн
-88,00 млн
-91,00 млн
-245,00 млн
Depreciation and amortization charges
-
-
-
22,64 млрд
EBITDA
17,09 млрд
15,00 млрд
16,79 млрд
16,81 млрд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары